Skip to main content

Advertisement

Log in

A logistic regression model for predicting malignant pheochromocytomas

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

It is well known that no single histological feature is diagnostic for malignant pheochromocytomas (PCCs). So we developed a logistic model based on a series of clinical and pathological features to predict malignance in PCCs, and evaluated its diagnostic performance. In all 130 cases with malignant or benign PCCs, 15 predictive variables were observed and entered in the logistic regression analysis in a backward stepwise way. The diagnostic performance of this logistic model was evaluated by calculating the area under the receiver operating characteristic (ROC) curve. In logistic analysis, of the 15 variables entered in the logistic regression analysis, 9 were retained in the model. High cellularity had the highest odds ratio (OR), followed by spindle cell (>10% of tumor volume), atypical mitotic figure, periadrenal adipose tissue invasion, mitotic figures [>3/10 high-power field (HPF)], cellular monotony, capsular invasion, vascular invasion, and central or confluent tumor necrosis. High cellularity, spindle cell (>10% of tumor volume) and atypical mitotic figure were selected to built a logistic model. This model had the area under the ROC curve of 0.927 (95% confidence interval 0.883–0.971). The application of the model can benefit the clinical management decision for patients with PCCs. We still emphasize, however, that a clinical prospective evaluation is needed to confirm its actual value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Allibhai Z et al (2004) Malignant pheochromocytoma associated with germline mutation of the SDHB gene. J Urol 172(4 Pt 1):1409–1410

    Article  PubMed  Google Scholar 

  • Anouar Y et al (2006) Development of novel tools for the diagnosis and prognosis of pheochromocytoma using peptide marker immunoassay and gene expression profiling approaches. Ann N Y Acad Sci 1073:533–540

    Article  PubMed  Google Scholar 

  • Arnaldi G et al (2000) Adrenal incidentaloma. Braz J Med Biol Res 33(10):1177–1189

    Article  PubMed  CAS  Google Scholar 

  • Aslam N et al (2000) Prospective evaluation of logistic regression models for the diagnosis of ovarian cancer. Obstet Gynecol 96(1):75–80

    Article  PubMed  CAS  Google Scholar 

  • Bautista CV et al (2007) Telomerase activity is a prognostic factor for recurrence and survival in rectal cancer. Dis Colon Rectum 50:611–620

    Article  PubMed  Google Scholar 

  • Brouwers FM et al (2006) Gene expression profiling of benign and malignant pheochromocytoma. Ann N Y Acad Sci 1073:541–556

    Article  PubMed  CAS  Google Scholar 

  • Cassidy LD (2005) Basic concepts of statistical analysis for surgical research. J Surg Res 128:199–206

    Article  PubMed  Google Scholar 

  • Favier J et al (2002) Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am J Pathol 161(4):1235–1246

    PubMed  CAS  Google Scholar 

  • Melicow MM (1977) One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926–1976: a clinicopathological analysis. Cancer 40(5):1987–2004

    Article  PubMed  CAS  Google Scholar 

  • Modlin IM et al (1979) Phaeochromocytomas in 72 patients: clinical and diagnostic features, treatment and long term results. Br J Surg 66(7):456–465

    Article  PubMed  CAS  Google Scholar 

  • Obuchowski NA (2005) ROC analysis. AJR Am J Roentgenol 184(2):364–372

    PubMed  Google Scholar 

  • Salmenkivi K et al (2001) Inhibin/activin betaB-subunit expression in pheochromocytomas favors benign diagnosis. J Clin Endocrinol Metab 86(5):2231–2235

    Article  PubMed  CAS  Google Scholar 

  • Salmenkivi K et al (2001) Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. J Clin Endocrinol Metab 86(11):5615–5619

    Article  PubMed  CAS  Google Scholar 

  • Scott HW Jr et al (1982) Clinical experience with malignant pheochromocytomas. Surg Gynecol Obstet 154(6):801–818

    PubMed  Google Scholar 

  • Segawa N, Osafune T (2005) Malignant pheochromocytoma of the urinary bladder. Hinyokika Kiyo 51(4):291–296

    PubMed  Google Scholar 

  • Steyerberg EW et al (2004) Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med 23(16):2567–2586

    Article  PubMed  Google Scholar 

  • Vergouwe Y et al (2005) Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol 58(5):475–483

    Article  PubMed  Google Scholar 

  • Wada K et al (2005) Chromosomal and genetic abnormalities in benign and malignant meningiomas using DNA microarray. Neurol Res 27(7):747–754

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhishun Xu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gao, B., Sun, Y., Liu, Z. et al. A logistic regression model for predicting malignant pheochromocytomas. J Cancer Res Clin Oncol 134, 631–634 (2008). https://doi.org/10.1007/s00432-007-0261-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-007-0261-6

Keywords

Navigation